Literature DB >> 7680524

Mutational analysis of a patient with mucopolysaccharidosis type VII, and identification of pseudogenes.

J M Shipley1, M Klinkenberg, B M Wu, D R Bachinsky, J H Grubb, W S Sly.   

Abstract

PCR of cDNA produced from patient fibroblasts allowed us to determine the paternal mutation in the first patient reported with beta-glucuronidase-deficiency mucopolysaccharidosis type VII (MPS VII). The G-->T transversion 1,881 bp downstream of the ATG translation initiation codon destroys an MboII restriction site and converts Trp627 to Cys (W627C). Digestion of genomic DNA PCR fragments with MboII indicated that the patient and the father were heterozygous for this missense mutation in exon 12. Failure to find cDNAs from patient RNA which did not contain this mutation suggested that the maternal mutation leads to greatly reduced synthesis or reduced stability of mRNA from the mutant allele. In order to identify the maternal mutation, it was necessary to analyze genomic sequences. This approach was complicated by the finding of multiple unprocessed pseudogenes and/or closely related genes. Using PCR with a panel of human/rodent hybrid cell lines, we found that these pseudogenes were present over chromosomes 5-7, 20, and 22 and the Y chromosome. Conditions were defined which allowed us to amplify and characterize genomic sequences for the true beta-glucuronidase gene despite this background of related sequences. The patient proved to be heterozygous for a second mutation, in which a C-->T transition introduces a termination codon (R356STOP) in exon 7. The mother was also heterozygous for this mutation. Expression of a cDNA containing the maternal mutation produced no enzyme activity, as expected. Expression of the paternal mutation in COS-7 cells produced a surprisingly high (65% of control) level of activity. However, activity was 13% of control in transiently transfected murine MPS VII cells. The level of activity of this mutant allele appears to correlate with the level of overexpression, suggesting that high concentrations of mutant monomers can drive the folding and tetramerization of mutant enzyme to produce an active and stable enzyme.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7680524      PMCID: PMC1682147     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  35 in total

1.  Purification and properties of beta-glucuronidase from human placenta.

Authors:  F E Brot; C E Bell; W S Sly
Journal:  Biochemistry       Date:  1978-02-07       Impact factor: 3.162

2.  Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis.

Authors:  W S Sly; B A Quinton; W H McAlister; D L Rimoin
Journal:  J Pediatr       Date:  1973-02       Impact factor: 4.406

3.  Identification of DNA sequences required for transcription of the human alpha 1-globin gene in a new SV40 host-vector system.

Authors:  P Mellon; V Parker; Y Gluzman; T Maniatis
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

4.  SV40-transformed simian cells support the replication of early SV40 mutants.

Authors:  Y Gluzman
Journal:  Cell       Date:  1981-01       Impact factor: 41.582

5.  New M13 vectors for cloning.

Authors:  J Messing
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

6.  Expression of a recombinant DNA gene coding for the vesicular stomatitis virus nucleocapsid protein.

Authors:  J Sprague; J H Condra; H Arnheiter; R A Lazzarini
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

7.  Beta-glucuronidase deficiency mucopolysaccharidosis: methods for enzymatic diagnosis.

Authors:  J H Glaser; W S Sly
Journal:  J Lab Clin Med       Date:  1973-12

8.  Nonsense-codon mutations of the ornithine aminotransferase gene with decreased levels of mutant mRNA in gyrate atrophy.

Authors:  Y Mashima; A Murakami; R G Weleber; N G Kennaway; L Clarke; T Shiono; G Inana
Journal:  Am J Hum Genet       Date:  1992-07       Impact factor: 11.025

9.  High efficiency polyoma DNA transfection of chloroquine treated cells.

Authors:  H Luthman; G Magnusson
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  21 in total

Review 1.  The role of beta-glucuronidase in drug disposition and drug targeting in humans.

Authors:  B Sperker; J T Backman; H K Kroemer
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

2.  Composite exon structure of an unusual Ig lambda-like gene located at human 22q11 position.

Authors:  C Schiff; M Milili; J Zucman-Rossi; M Djabali; M Fougereau
Journal:  Mamm Genome       Date:  1996-08       Impact factor: 2.957

3.  Missense models [Gustm(E536A)Sly, Gustm(E536Q)Sly, and Gustm(L175F)Sly] of murine mucopolysaccharidosis type VII produced by targeted mutagenesis.

Authors:  Shunji Tomatsu; Koji O Orii; Carole Vogler; Jeffrey H Grubb; Elizabeth M Snella; Monica A Gutierrez; Tatiana Dieter; Kazuko Sukegawa; Tadao Orii; Naomi Kondo; William S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-28       Impact factor: 11.205

4.  A rearrangement on chromosome 5 of an expressed human beta-glucuronidase pseudogene.

Authors:  C A Sargent; I J Chalmers; M Leversha; N A Affara
Journal:  Mamm Genome       Date:  1994-12       Impact factor: 2.957

Review 5.  Large animal models of neurological disorders for gene therapy.

Authors:  Christine Gagliardi; Bruce A Bunnell
Journal:  ILAR J       Date:  2009

6.  Molecular analysis of patients with beta-glucuronidase deficiency presenting as hydrops fetalis or as early mucopolysaccharidosis VII.

Authors:  R Vervoort; M R Islam; W S Sly; M T Zabot; W J Kleijer; A Chabas; A Fensom; E P Young; I Liebaers; W Lissens
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

7.  Central nervous system delivery of helper-dependent canine adenovirus corrects neuropathology and behavior in mucopolysaccharidosis type VII mice.

Authors:  Lorena Ariza; Lydia Giménez-Llort; Aurélie Cubizolle; Gemma Pagès; Belén García-Lareu; Nicolas Serratrice; Dan Cots; Rosemary Thwaite; Miguel Chillón; Eric J Kremer; Assumpció Bosch
Journal:  Hum Gene Ther       Date:  2014-01-23       Impact factor: 5.695

8.  Complex repetitive arrangements of gene sequence in the candidate region of the spinal muscular atrophy gene in 5q13.

Authors:  A M Theodosiou; K E Morrison; A M Nesbit; R J Daniels; L Campbell; M J Francis; Z Christodoulou; K E Davies
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

9.  Biochemical properties of recombinant human beta-glucuronidase synthesized in baby hamster kidney cells.

Authors:  M C Gehrmann; M Opper; H H Sedlacek; K Bosslet; J Czech
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

10.  A pseudodeficiency allele (D152N) of the human beta-glucuronidase gene.

Authors:  R Vervoort; M R Islam; W Sly; A Chabas; R Wevers; J de Jong; I Liebaers; W Lissens
Journal:  Am J Hum Genet       Date:  1995-10       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.